As seen in the DESTINY-Breast06 trial, a pproximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast cancer patients may be considered HER2-ultralow.1 These patients may now be ...
The automotive plastic additives market is advancing, driven by the need for lightweight materials, enhanced durability, and improved performance in automotive manufacturing.” - Exactitude Consultancy ...